|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Correction of Error Regarding Malaria Treatment in Disease-A-MonthIn the March 1984 issue of Disease-A-Month, an article entitled, "Tropical Diseases of North America," appeared. In Table 5, "Malaria Prophylaxis and Therapy" on page 39, a potentially serious error of dosage appeared--the pediatric dose of primaquine phosphate was printed in error as 5 mg/kg/day x 14 days. This is 10 times the correct dose, which is 0.5 mg/kg/day (or 0.3 mg/kg/day of primaquine base) x 14 days. Since primaquine has a relatively low therapeutic index, the stated dose could lead to significant toxicity, and this correction should be noted. The stated maximum dose ("not to exceed 26.3 mg/day") is correct. Disclaimer All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 08/05/98 |
|||||||||
This page last reviewed 5/2/01
|